Presentation: First Report of Phase Ib/2a Study Evaluating Safety and Early Efficacy of TN-201, an Adeno-Associated Virus ...
Poor performance on quality metrics carried greater risk of in-hospital mortality no matter where patients initially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results